La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

MedCap Crescita futura

Future criteri di controllo 0/6

Al momento non disponiamo di una copertura analitica sufficiente per prevedere la crescita e il fatturato di MedCap.

Informazioni chiave

n/a

Tasso di crescita degli utili

n/a

Tasso di crescita dell'EPS

Life Sciences crescita degli utili	48.7%
Tasso di crescita dei ricavi	n/a
Rendimento futuro del capitale proprio	n/a
Copertura analitica	None
Ultimo aggiornamento	n/a

Aggiornamenti recenti sulla crescita futura

Nessun aggiornamento

Recent updates

Estimating The Intrinsic Value Of MedCap AB (publ) (STO:MCAP)

Jun 06

MedCap AB (publ) (STO:MCAP) Stocks Shoot Up 33% But Its P/E Still Looks Reasonable

May 21

Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?

May 04

MedCap AB (publ)'s (STO:MCAP) P/E Is Still On The Mark Following 25% Share Price Bounce

Feb 15

Declining Stock and Solid Fundamentals: Is The Market Wrong About MedCap AB (publ) (STO:MCAP)?

Jan 22

Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?

Jan 07

MedCap (STO:MCAP) Is Growing Earnings But Are They A Good Guide?

Dec 22

If You Had Bought MedCap (STO:MCAP) Stock Five Years Ago, You Could Pocket A 663% Gain Today

Dec 08

Are Insiders Selling MedCap AB (publ) (STO:MCAP) Stock?

Nov 23

In questa sezione di solito presentiamo le proiezioni di crescita dei ricavi e degli utili basate sulle stime di consenso degli analisti professionisti per aiutare gli investitori a capire la capacità della società di generare profitti. Tuttavia, poiché MedCap non ha fornito dati sufficienti sul passato e non ha previsioni degli analisti, i suoi utili futuri non possono essere calcolati in modo affidabile estrapolando i dati passati o utilizzando le previsioni degli analisti.

Si tratta di una situazione piuttosto rara, dato che il 97% delle società coperte da SimplyWall St dispone di dati finanziari passati.

Previsioni di crescita degli utili e dei ricavi

OM:MCAP - Stime future degli analisti e dati finanziari passati (SEK Millions )
Data	Ricavi	Guadagni	Flusso di cassa libero	Liquidità dell'operazione	Avg. Numero di analisti
6/30/2024	1,753	214	244	299	N/A
3/31/2024	1,681	203	219	268	N/A
12/31/2023	1,600	172	189	228	N/A
9/30/2023	1,466	150	77	114	N/A
6/30/2023	1,343	149	61	97	N/A
3/31/2023	1,241	123	47	82	N/A
12/31/2022	1,124	118	41	86	N/A
9/30/2022	1,056	118	100	167	N/A
6/30/2022	1,017	107	78	146	N/A
3/31/2022	967	102	85	156	N/A
12/31/2021	926	97	55	116	N/A
9/30/2021	896	76	77	109	N/A
6/30/2021	869	64	60	90	N/A
3/31/2021	845	67	79	104	N/A
12/31/2020	828	63	91	115	N/A
9/30/2020	802	55	64	88	N/A
6/30/2020	786	53	75	101	N/A
3/31/2020	763	47	38	62	N/A
12/31/2019	757	55	41	71	N/A
9/30/2019	734	43	80	87	N/A
6/30/2019	740	41	70	107	N/A
3/31/2019	727	32	64	103	N/A
12/31/2018	709	24	56	91	N/A
9/30/2018	716	14	19	57	N/A
6/30/2018	689	8	13	27	N/A
3/31/2018	660	10	N/A	46	N/A
12/31/2017	617	7	N/A	41	N/A
10/31/2017	779	11	N/A	79	N/A
7/31/2017	802	3	N/A	85	N/A
4/30/2017	853	0	N/A	81	N/A
1/31/2017	901	5	N/A	32	N/A
10/31/2016	897	10	N/A	-18	N/A
7/31/2016	874	19	N/A	-44	N/A
4/30/2016	818	20	N/A	-15	N/A
1/31/2016	817	18	N/A	-60	N/A
10/31/2015	818	17	N/A	-28	N/A
7/31/2015	825	8	N/A	14	N/A
4/30/2015	855	9	N/A	2	N/A
1/31/2015	891	9	N/A	50	N/A
10/31/2014	913	15	N/A	26	N/A
7/31/2014	910	21	N/A	-1	N/A
4/30/2014	827	23	N/A	1	N/A
1/31/2014	651	18	N/A	29	N/A
10/31/2013	517	11	N/A	47	N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: Dati insufficienti per determinare se la crescita degli utili prevista MCAP è superiore al tasso di risparmio ( 1.1% ).

Guadagni vs Mercato: Dati insufficienti per determinare se si prevede che gli utili di MCAP cresceranno più velocemente del mercato Swedish

Guadagni ad alta crescita: Dati insufficienti per determinare se si prevede che gli utili di MCAP cresceranno in modo significativo nei prossimi 3 anni.

Ricavi vs Mercato: Dati insufficienti per determinare se si prevede che i ricavi di MCAP cresceranno più rapidamente del mercato Swedish.

Ricavi ad alta crescita: Dati insufficienti per determinare se si prevede che i ricavi di MCAP cresceranno più rapidamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Dati insufficienti per determinare se il Return on Equity di MCAP è previsto essere elevato tra 3 anni

MedCap Crescita futura

Future criteri di controllo 0/6

Informazioni chiave

Aggiornamenti recenti sulla crescita futura

Recent updates

Chief Executive Officer recently bought kr265k worth of stock

Second quarter 2024 earnings released: EPS: kr3.84 (vs kr3.16 in 2Q 2023)

MedCap AB (publ) to Report Q2, 2025 Results on Jul 23, 2025

Now 17% undervalued

Now 21% undervalued

Estimating The Intrinsic Value Of MedCap AB (publ) (STO:MCAP)

MedCap AB (publ) (STO:MCAP) Stocks Shoot Up 33% But Its P/E Still Looks Reasonable

Now 21% undervalued

MedCap AB (publ) to Report Q1, 2025 Results on Apr 29, 2025

Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?

First quarter 2024 earnings released: EPS: kr3.78 (vs kr1.68 in 1Q 2023)

MedCap AB (publ), Annual General Meeting, May 06, 2024

MedCap AB (publ) to Report Fiscal Year 2024 Results on Jan 31, 2025

MedCap AB (publ)'s (STO:MCAP) P/E Is Still On The Mark Following 25% Share Price Bounce

Full year 2023 earnings released: EPS: kr11.63 (vs kr7.94 in FY 2022)

Investor sentiment improves as stock rises 19%

Is Now The Time To Put MedCap (STO:MCAP) On Your Watchlist?

MedCap AB (publ) to Report Q3, 2024 Results on Oct 25, 2024

Third quarter 2023 earnings released: EPS: kr2.59 (vs kr2.47 in 3Q 2022)

MedCap AB (publ) to Report First Half, 2024 Results on Jul 19, 2024

Second quarter 2023 earnings released: EPS: kr3.16 (vs kr1.42 in 2Q 2022)

MedCap AB (publ) (OM:MCAP) signed an agreement to acquire SurgiCube International B.V. for €8 million.

Do MedCap's (STO:MCAP) Earnings Warrant Your Attention?

MedCap AB (publ) to Report Q1, 2024 Results on May 03, 2024

First quarter 2023 earnings released: EPS: kr1.68 (vs kr1.32 in 1Q 2022)

Full year 2022 earnings released: EPS: kr7.94 (vs kr6.52 in FY 2021)

These 4 Measures Indicate That MedCap (STO:MCAP) Is Using Debt Safely

High number of new and inexperienced directors

Third quarter 2022 earnings released: EPS: kr2.47 (vs kr1.73 in 3Q 2021)

We Ran A Stock Scan For Earnings Growth And MedCap (STO:MCAP) Passed With Ease

Now 21% undervalued

Now 21% undervalued

MedCap AB (publ) to Report Q2, 2023 Results on Jul 28, 2023

High number of new and inexperienced directors

MedCap AB (publ) to Report Q2, 2023 Results on Jul 28, 2023

MedCap AB (publ) to Report Q3, 2022 Results on Oct 28, 2022

High number of new and inexperienced directors

MedCap AB (publ) to Report Q1, 2023 Results on May 03, 2023

First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Does MedCap (STO:MCAP) Deserve A Spot On Your Watchlist?

MedCap AB (publ) to Report Q4, 2022 Results on Feb 10, 2023

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

MedCap (STO:MCAP) Seems To Use Debt Rather Sparingly

Investor sentiment improved over the past week

Now 22% undervalued after recent price drop

High number of new directors

Chief Executive Officer recently bought kr348k worth of stock

Investment Manager recently bought kr828k worth of stock

Third quarter 2021 earnings released: EPS kr1.73 (vs kr0.89 in 3Q 2020)

Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?

Second quarter 2021 earnings released: EPS kr1.06 (vs kr1.33 in 2Q 2020)

Does MedCap (STO:MCAP) Have A Healthy Balance Sheet?

Investor sentiment deteriorated over the past week

Independent Chairman of the Board recently bought kr1.1m worth of stock

Here's Why I Think MedCap (STO:MCAP) Is An Interesting Stock

Imagine Holding MedCap (STO:MCAP) Shares While The Price Zoomed 558% Higher

Have Insiders Been Selling MedCap AB (publ) (STO:MCAP) Shares?

Revenue and earnings beat expectations

Full year 2020 earnings released: EPS kr4.36 (vs kr4.10 in FY 2019)

New 90-day low: kr193

MedCap (STO:MCAP) Could Easily Take On More Debt

Declining Stock and Solid Fundamentals: Is The Market Wrong About MedCap AB (publ) (STO:MCAP)?

An unknown buyer acquired 10.1% stake in MedCap AB (publ) (OM:MCAP) from Bure Equity AB (publ) (OM:BURE).

Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?

MedCap (STO:MCAP) Is Growing Earnings But Are They A Good Guide?

If You Had Bought MedCap (STO:MCAP) Stock Five Years Ago, You Could Pocket A 663% Gain Today

Market bids up stock over the past week

New 90-day high: kr233

Are Insiders Selling MedCap AB (publ) (STO:MCAP) Stock?

Revenue and earnings miss expectations

Third quarter 2020 earnings released: EPS kr0.89

New 90-day high: kr227

New 90-day high - kr207

MedCap AB (publ) to Report Q2, 2021 Results on Jul 30, 2021

Previsioni di crescita degli utili e dei ricavi